Advertisement
ResearchIn-Press PreviewImmunologyOphthalmology
Open Access |
10.1172/JCI205838
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Voigt, A. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Gong, J. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Droho, S. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Mulfaul, K. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Rajesh, A. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Forbes, G. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Sterling, J. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Flamme-Wiese, M. in: PubMed | Google Scholar
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by
Mullins, R.
in:
PubMed
|
Google Scholar
|
1Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
2Institute for Vision Research, The University of Iowa, Iowa City, United States of America
Find articles by Lavine, J. in: PubMed | Google Scholar
Published October 8, 2026 - More info
The human retina and underlying choroid have multiple well-organized vascular layers. However, retinal and choroidal neovascularization can develop in diseases such as diabetic retinopathy or neovascular age-related macular degeneration, which can result in destructive vision loss. Ocular macrophages are implicated in the pathogenesis of such neovascular diseases. To identify a potential pro-angiogenic macrophage subtype, we integrated 13 single-cell RNA sequencing datasets from human and mouse eyes comprising 173 unique samples. From 99,184 mononuclear phagocytes, we identified a single macrophage subtype with high expression of SPP1, FABP5, and IL7R that was over-represented from neovascular disease samples. We fate mapped these cells and specifically depleted them, showing that they are monocyte-derived and necessary for laser-induced choroidal neovascularization in mice. Finally, we performed a high-resolution spatial RNA sequencing experiment on six human donors and found that the pro-angiogenic macrophage subtype localized to human choroidal neovascular membranes. These macrophages and other cells in neovascular membranes expressed MMP14, a potential therapeutic target, and MMP14 inhibition decreased choroidal neovascularization in mice. Collectively, we show that this Monocyte-derived Pro-angiogenic Ocular Macrophage (MoPOM) subtype is upregulated in multiple ocular neovascular diseases across species, necessary for choroidal neovascularization, and is a potential therapeutic target to reduce destructive angiogenesis in the eye.